STERIS plc (NYSE:STE) Rating Changes as of May 17, 2018

May 17, 2018 - By Laura Small

STERIS plc (NYSE:STE) Corporate Logo
During 2017 Q4 the big money sentiment decreased to 0.17. That’s change of 0.33, from 2017Q3’s 0.5. 4 investors sold all, 2 reduced holdings as STERIS plc ratio turned negative. 0 rose holdings while 1 funds took holdings. Funds hold 19,649 shares thus 85.67% less from 2017Q3’s 137,131 shares.
Hanson And Doremus Invest Mngmt reported 1,500 shs. Shine Advisory Service invested in 0.01% or 123 shs. Fruth Investment holds 0.52% or 14,076 shs. Alphamark Advisors Limited Liability holds 0.01% or 150 shs in its capital. 3,800 are held by Prudential Public Limited Liability Com.

STERIS plc (NYSE:STE) Ratings Coverage

Total analysts of 3 have positions in STERIS (NYSE:STE) as follows: 2 rated it a “Buy”, 0 with “Sell” and 1 with “Hold”. The positive are 67%. Since January 3, 2018 according to StockzIntelligence Inc STERIS has 3 analyst reports. On Wednesday, January 3 the stock of STERIS plc (NYSE:STE) earned “Market Perform” rating by Raymond James. In Thursday, February 8 report Northcoast maintained the stock with “Buy” rating. On Thursday, February 8 KeyBanc Capital Markets maintained STERIS plc (NYSE:STE) with “Buy” rating. Listed here are STERIS plc (NYSE:STE) PTs and latest ratings.

08/02/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $103.0 Maintain
08/02/2018 Broker: Northcoast Rating: Buy New Target: $102.0 Maintain
03/01/2018 Broker: Raymond James Old Rating: Outperform New Rating: Market Perform Old Target: $100 Downgrade

The stock increased 0.35% or $0.36 during the last trading session, touching $103.28.STERIS plc has volume of 302,150 shares. Since May 17, 2017 STE has risen 32.31% and is uptrending. STE outperformed the S&P 500 by 20.76%.

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support services and products for healthcare, pharmaceutical, scientific, research, industrial, and governmental clients worldwide.The company has $8.76 billion market cap. The companyÂ’s Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories.The P/E ratio is 36.38. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products.

There’s a substantial STERIS plc (NYSE:STE) news brought out by Seekingalpha.com. It’s a report titled: “STERIS Plc (STE) Q4 2018 Results – Earnings Call Transcript” on May 09, 2018.

STERIS plc (NYSE:STE) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.